Aware Super Pty Ltd as trustee of Aware Super Cuts Stake in Molina Healthcare, Inc $MOH

Aware Super Pty Ltd as trustee of Aware Super lessened its stake in Molina Healthcare, Inc (NYSE:MOH) by 87.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 975 shares of the company’s stock after selling 7,056 shares during the quarter. Aware Super Pty Ltd as trustee of Aware Super’s holdings in Molina Healthcare were worth $290,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. Price T Rowe Associates Inc. MD raised its stake in shares of Molina Healthcare by 46.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,838,043 shares of the company’s stock worth $1,264,214,000 after purchasing an additional 1,216,903 shares during the last quarter. AQR Capital Management LLC raised its position in Molina Healthcare by 42.7% in the 1st quarter. AQR Capital Management LLC now owns 884,958 shares of the company’s stock worth $288,125,000 after buying an additional 264,664 shares during the last quarter. Nuveen LLC bought a new position in Molina Healthcare during the 1st quarter valued at about $46,441,000. T. Rowe Price Investment Management Inc. lifted its stake in Molina Healthcare by 8.6% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 1,487,896 shares of the company’s stock valued at $490,099,000 after acquiring an additional 117,796 shares during the period. Finally, Durable Capital Partners LP boosted its holdings in shares of Molina Healthcare by 13.1% during the 1st quarter. Durable Capital Partners LP now owns 541,605 shares of the company’s stock valued at $178,399,000 after acquiring an additional 62,899 shares during the last quarter. 98.50% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Molina Healthcare news, Director Ronna Romney sold 700 shares of Molina Healthcare stock in a transaction that occurred on Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total transaction of $107,618.00. Following the transaction, the director owned 17,131 shares of the company’s stock, valued at $2,633,719.94. The trade was a 3.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, COO James Woys purchased 10,000 shares of the company’s stock in a transaction on Monday, August 4th. The stock was purchased at an average price of $155.94 per share, with a total value of $1,559,400.00. Following the completion of the transaction, the chief operating officer owned 74,331 shares of the company’s stock, valued at approximately $11,591,176.14. This trade represents a 15.54% increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.10% of the stock is currently owned by company insiders.

Molina Healthcare Price Performance

NYSE MOH opened at $192.33 on Thursday. The business’s fifty day moving average is $180.58 and its 200 day moving average is $246.65. Molina Healthcare, Inc has a fifty-two week low of $151.95 and a fifty-two week high of $359.97. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.66 and a current ratio of 1.66. The company has a market capitalization of $10.42 billion, a PE ratio of 9.48 and a beta of 0.55.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings results on Wednesday, July 23rd. The company reported $5.48 EPS for the quarter, missing analysts’ consensus estimates of $5.50 by ($0.02). Molina Healthcare had a return on equity of 27.72% and a net margin of 2.60%.The company had revenue of $11.43 billion during the quarter, compared to analysts’ expectations of $10.94 billion. During the same quarter in the previous year, the company earned $5.86 EPS. The business’s quarterly revenue was up 15.7% compared to the same quarter last year. Sell-side analysts predict that Molina Healthcare, Inc will post 24.4 earnings per share for the current year.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the stock. Cantor Fitzgerald restated a “neutral” rating and set a $210.00 price objective on shares of Molina Healthcare in a research report on Tuesday, August 26th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Molina Healthcare in a research note on Wednesday, October 8th. JPMorgan Chase & Co. dropped their price target on Molina Healthcare from $272.00 to $184.00 and set a “neutral” rating on the stock in a research note on Tuesday, July 29th. Mizuho reduced their price objective on Molina Healthcare from $400.00 to $330.00 and set an “outperform” rating for the company in a research report on Friday, July 11th. Finally, Wells Fargo & Company increased their target price on Molina Healthcare from $198.00 to $231.00 and gave the company an “overweight” rating in a report on Tuesday, October 7th. Three equities research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Molina Healthcare currently has a consensus rating of “Hold” and a consensus price target of $223.75.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.